$SNPS

Synopsys Stock Jumps As AI Deals And Targets Impress Wall Street

Synopsys Inc. (NASDAQ: SNPS) shares rose 10.06% on October 1, 2026, driven by strong AI-chip design demand and upbeat guidance. The company reported $7.05B in revenue, 72.4% gross margin, and 30%+ EBITDA margin. SNPS projected 15% revenue growth for FY27, targeting $11.15B, and announced AI partnerships with Amazon and OpenAI. HSBC upgraded SNPS to Buy with a $700 target, citing high-growth AI potential.

Original reporting
Published Oct 1, 2026, 4:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 4:54 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Synopsys Stock Jumps As AI Deals And Targets Impress Wall Street — source image
Decision brief

The 30-second read

$SNPSBullishHigh
01

Why it matters

The combination of high‑profile AI partnerships and upgraded guidance is a catalyst for short‑term price appreciation, but valuation risks remain.

02

Market read

The news directly drove a 10% intraday rally, indicating high immediate relevance for traders.

03

What to watch

Potential supply‑chain constraints at foundries and macro‑economic slowdown could dampen AI spend.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Synopsys is a leading EDA software provider; AI integration is a strategic priority driving recent growth.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys stock surged 10% on fresh AI-chip design deals with Amazon and OpenAI, upgraded FY27 guidance and a buy rating upgrade.

Expected impact

likely further upside as traders price in AI growth, with potential pullbacks if guidance is not met

Evidence & confidence

Deal announcements and guidance are primary disclosures that moved the stock; market reaction has been strong and the upgrade adds credibility.

Market effects

strengthens the AI‑enabled EDA sector, prompting re‑rating of peers like Cadence and Mentor

U.S. tech market gains on AI hype, modest spillover to Asian semiconductor suppliers

reinforces global AI supply‑chain narrative, may lift broader AI‑related indices

Counterpoint

The stock's lofty P/E and reliance on a few large contracts could trigger a sharp correction if any deal stalls.

Key entities

  • Synopsys Inc.

    U.S. listed EDA software vendor (NASDAQ: SNPS)

  • Amazon.com Inc.

    Signed multi‑year AI‑chip design agreement with Synopsys

  • OpenAI

    Collaborating on GPT‑Synopsys integration

Related articles

$SNPSHigh

Synopsys Stock Rises 9%

Synopsys (SNPS) stock rose 9.38% to $475.74 on Thursday, following a strategic partnership with OpenAI to develop GPT-Synopsys, an AI model for semiconductor design. The company's stock traded between $462.00 and $493.30 with higher-than-average volume. The 52-week range is $362.55 to $539.48.

$ACNMed

Stocks making the biggest moves midday: Accenture, Synopsys, United Therapeutics, Vicor and more

Accenture rose 18% after Q4 revenue of $18.7B beat estimates. McCormick's Q3 results topped expectations but shares fell 2% amid Unilever's acquisition. McKesson gained 4% on reaffirmed guidance and a CVS Health partnership. United Therapeutics climbed 6% after a court ruling, while Liquidia dropped 15%. Constellation Energy gained 3% on a 20-year Amazon deal. Synopsys jumped 8% with 2027 revenue targets. Sigma Lithium slid 16% after halting production.

$SNPSHighAI 9/10

Why Synopsys Stock Soared on Thursday

Synopsys (SNPS) stock rose 12.5% after the company projected 2027 revenue up to $11.2B, higher than analysts' $9.7B estimate for 2026. It expects 2027 free cash flow of $3.1B and operating margins of 20.7%. GAAP EPS is forecast at $8.16-$8.61, while non-GAAP EPS is projected at $19.04-$19.12.

$SNPSMedAI 8/10

Synopsys Stock Jumps As AI Deals And Targets Power SNPS

Synopsys Inc. (NASDAQ: SNPS) stock rose 9.91% on October 1, 2026, driven by strong AI-chip design demand and upbeat guidance. The company reported $7.05B in trailing revenue, 72% gross margin, and guided to 15% annual revenue growth, targeting $11.15B in FY27. Recent partnerships with Amazon, OpenAI, and TSMC bolster its AI and chip design narrative. HSBC upgraded SNPS to Buy with a $700 target.